Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Abbasi, S., Orlicek, S.L., Almohsen, I., Luedtke, G., and English, B.K. (1996). Septic arthritis and osteomyelitis caused by penicillin and cephalosporin-resistant Streptococcus pneumoniae in a children’s hospital. Pediatr. Infect. Dis. J. 15, 78–83.
Adam, D. (2002) Global antibiotic resistance in Streptococcus pneumoniae. J. Antimicrob. Chemother. 50,Suppl: 1–5.
Adem, P.V., Montgomery, C.P., Husain, A.N., Koogler, T.K., Arangelovich, V., Humilier, M., Boyle-Vavra, S., and Daum, R.S. (2005). Brief Report: Staphylococcus aureus Sepsis and the Waterhouse-Friderichsen Syndrome in Children. N. Engl. J. Med. 353, 1245–51.
Alfaro, C., Fergie, J., and Purcell, K. (2005). Emergence of community-acquired methicillin-resistant Staphylococcus aureus in complicated parapneumonic effusions. Pediatr. Infect. Dis. J. 24, 274–6.
American Academy of Pediatrics, Committee on Infectious Diseases (1997). Therapy for children with invasive pneumococcal infections. Pediatrics 99, 289–99.
Applebaum, P.C. (2002) Resistance among Streptococcus pneumoniae: implications for drug selection. Clin. Infect. Dis. 34, 1613–20.
Aspa, J., Rajas, O., Rodriguez de Castro, F., Blanquer, J., Zalacain R., Fenoll, A., de Celis, R., Vargas, A., Rodriguez Salvanes, F., Espana, P.P., Rello, J., and Torres, A. (2004). Pneumococcal Pneumonia in Spain Study Group. Drug-resistant pneumococcal pneumonia: clinical relevance and related factors. Clin. Infect. Dis. 38, 787–98.
Austrian, R., and Gold, J. (1964) Pneumococcal bacteremia with especial reference to bacteremic pneumococcal pneumonia. Ann. Intern. Med 60, 759–70.
Barrett, F.F., McGehee, R.F., Jr., and Finland, M. (1968). Methicillin-resistant Staphylococcus aureus at Boston City Hospital. Bacteriologic and epidemiologic observations. N. Engl. J. Med. 279, 441–8.
Black, S.B., Shinefield, H.R., Ling, S., Hansen, J., Fireman, B., Spring, D., Noyes, J., Lewis, E., Ray, P., Lee, J., and Hackell, J. (2002). Effectiveness of heptavalent pneumococcal conjugate vaccine in children younger than five years of age for prevention of pneumonia. Pediatr. Infect. Dis. J. 21, 810–5.
Bradley, J.S., and Connor, J.D. (1991). Ceftriaxone failure in meningitis caused by Streptococcus pneumoniae with reduced susceptibility to beta-lactam antibiotics. Pediatr. Infect. Dis. J. 10, 871–3.
Bradley, J.S. (2002). Management of community-acquired pediatric pneumonia in an era of increasing antibiotic resistance and conjugate vaccines. Pediatr. Infect. Dis. J. 21, 592–8.
Braun, L., Craft, D., Williams, R., Tuamokumo, F., and Ottolini, M. (2005). Increasing clindamycin resistance among methicillin-resistant Staphylococcus aureus in 57 northeast United States military treatment facilities. Pediatr. Infect. Dis. J. 24, 622–6.
Buckingham, S.C., Brown, S.P., and Joaquin, V.H. (1998). Breakthrough bacteremia and meningitis during treatment with cephalosporins parenterally for pneumococcal pneumonia. J. Pediatr. 132, 174–6.
Buckingham, S.C., King, M.D., and Miller, M.L. (2003). Incidence and etiologies of complicated parapneumonic effusions in children, 1996 to 2001. Pediatr. Infect. Dis. J. 22, 499–504.
Buckingham, S.C., McDougal, L.K., Cathey, L.D., Comeaux, K., Craig, A.S., Fridkin, S.K., and Tenover, F.C. (2004). Emergence of community-associated methicillin-resistant Staphylococcus aureus at a Memphis, Tennessee Children’s Hospital. Pediatr. Infect. Dis. J. 23, 619–24.
Byington, C.L., Spencer, L.Y., Johnson, T.A., Pavia, A.T., Allen, D., Mason, E.O., Kaplan, S., Carroll, K.C., Daly, J.A., Christenson, J.C., and Samore, M.H. (2002). An epidemiological investigation of a sustained high rate of pediatric parapneumonic empyema: risk factors and microbiological associations. Clin. Infect. Dis. 34, 434–40.
Chartrand, S.A., and McCracken, G.H., Jr. (1982). Staphylococcal pneumonia in infants and children. Pediatr. Infect. Dis. J. 1, 19–23.
Chavez-Bueno, S., Bozdogan, B., Katz, K., Bowlware, K.L., Cushion, N., Cavuoti, D., Ahmad, N., McCracken, G.H., Jr., and Appelbaum, P.C. (2005). Inducible clindamycin resistance and molecular epidemiologic trends of pediatric community-acquired methicillin-resistant Staphylococcus aureus in Dallas, Texas. Antimicrob. Agents Chemother. 49, 2283–8.
Chickering, H.T., and Park, J.H. (1919) Staphylococcus aureus pneumonia. JAMA 72, 617–26.
Cunha, B.A. (2002). Clinical relevance of penicillin-resistant Streptococcus pneumoniae Semin. Respir. Infect. 17, 204–14.
Deeks, S.L., Palacio, R., Ruvinsky, R., Kertesz, D.A., Hortal, M., Rossi, A., Spika, J.S., and Di Fabio, J.L. (1999). Risk factors and course of illness among children with invasive penicillin-resistant Streptococcus pneumoniae. The Streptococcus pneumoniae Working Group. Pediatrics. 103, 409–13.
Dowell, S.F., Smith, T., Leversedge, K., and Snitzer, J. (1999). Failure of treatment of pneumonia associated with highly resistant pneumococci in a child. Clin. Infect. Dis. 29, 462–3.
Feikin, D.R., Schuchat, A., Kolczak, M., Barrett, N.L., Harrison, L.H., Lefkowitz, L., McGeer, A., Farley, M.M., Vugia, D.J., Lexau, C., Stefonek, K.R., Patterson, J.E., and Jorgensen, J.H. (2000). Mortality from invasive pneumococcal pneumonia in the era of antibiotic resistance, 1995–1997. Am. J. Public Health. 90, 223–9.
File, T.M., Jr. (2002). Appropriate use of antimicrobials for drug-resistant pneumonia: focus on the signifi cance of beta-lactam resistant Streptococcus pneumoniae. Clin. Infect. Dis. 34, S17–26.
File, T.M., Jr. (2004). Streptococcus pneumoniae and community-acquired pneumonia: a cause for concern. Am. J. Med. 117,Suppl 3A: 39S–50S.
Francis, J.S., Doherty, M.C., Lopatin, U., Johnston, C.P., Sinha, G., Ross, T., Cai, M., Hansel, N.N., Perl, T., Ticehurst, J.R., Carroll, K., Thomas, D.L., Nuermberger, E., and Bartlett, J.G. (2005). Severe community-onset pneumonia in healthy adults caused by methicillin-resistant Staphylococcus aureus carrying the Panton-Valentine leukocidin genes. Clin. Infect. Dis. 40, 100–7.
Frank, A.L., Marcinak, J.F., Mangat, P.D., Tjhio, J.T., Kelkar, S., Schreckenberger, P.C., and Quinn, J.P. (2002). Clindamycin treatment of methicillin-resistant Staphylococcus aureus infections in children. Pediatr. Infect. Dis. J. 21, 530–4.
Gonzalez, B.E., Martinez-Aguilar, G., Hulten, K.G., Hammerman, W.A., Coss-Bu, J., Avalos-Mishaan, A., Mason, E.O., Jr., and Kaplan, S.L. (2005). Severe Staphylococcal sepsis in adolescents in the era of community-acquired methicillin-resistant Staphylococcus aureus. Pediatrics. 115, 642–8.
Gonzalez, B.E., Hulten, K.G., Dishop, M.K., Lamberth, L.B., Hammerman, W.A., Mason, E.O., Jr., and Kaplan, S.L. (2005). Pulmonary manifestations in children with invasive community-acquired Staphylococcus aureus infection. Clin. Infect. Dis. 41, 583–90.
Gorak, E.J., Yamada, S.M., and Brown, J.D. (1999). Community-acquired methicillin-resistant Staphylococcus aureus in hospitalized adults and children without known risk factors. Clin. Infect. Dis. 29, 797–800.
Guillemot, D., Varon, E., Bernede, C., Weber, P., Henriet, L., Simon, S., Laurent, C., Lecoeur, H., and Carbon, C. (2005). Reduction of antibiotic use in the community reduces the rate of colonization with penicillin G-nonsusceptible Streptococcus pneumoniae. Clin. Infect. Dis. 41, 930–8.
Hardie, W., Bokulic, R., Garcia, V.F., Reising, S.F., and Christie, C.D. (1996). Pneumococcal pleural empyemas in children. Clin. Infect. Dis. 22, 1057–63.
Herold, B.C., Immergluck, L.C., Maranan, M.C., Lauderdale, D.S., Gaskin, R.E., Boyle-Vavra, S., Leitch, C.D., and Daum, R.S. (1998). Community-acquired methicillin-resistant Staphylococcus aureus in children with no identifi ed predisposing risk. JAMA 279, 593–8.
Hunt, C., Dionne, M., Delorme, M., et al. (1999). Four pediatric deaths from community-acquired methicillin-resistant Staphylococcus aureus: Minnesota and North Dakota, 1997–1999. MMWR 48, 707–10.
Kaplan, S.L., Afghani, B., Lopez, P., Wu, E., Fleishaker, D., Edge-Padbury, B., Naberhuis-Stehouwer, S., and Bruss, J.B. (2003). Linezolid for the treatment of methicillin-resistant Staphylococcus aureus infections in children. Pediatr. Infect. Dis. J. 22(Suppl), S178–85.
Kaplan, S.L., Hulten, K.G., Gonzalez, B.E., Hammerman, W.A., Lamberth, L., Versalovic, J., and Mason, E.O., Jr. (2005). Three-year surveillance of community-acquired Staphylococcus aureus infections in children. Clin. Infect. Dis. 40, 1785–91.
Karchmer, A.W. (1991). Staphylococcus aureus and vancomycin: the sequel. Ann. Intern. Med. 115, 739–41.
Klugman, K.P. (2002). The successful clone: the vector of dissemination of resistance in Streptococcus pneumoniae. J. Antimicrob. Chemother. 50(Suppl) S2, 1–5.
Kollef, M.H., Rello, J., Cammarata, S.K., Croos-Dabrera, R.V., and Wunderink, R.G. (2004). Clinical cure and survival in Gram-positive ventilator-associated pneumonia: retrospective analysis of two double-blind studies comparing linezolid with vancomycin. Intensive Care Med. 30, 388–94.
Levine, D.P., Fromm, B.S., and Reddy, B.R. (1991). Slow response to vancomycin or vancomycin plus rifampin in methicillin-resistant Staphylococcus aureus endocarditis. Ann. Intern. Med. 115, 674–80.
Lowy, F.D. (1998). Medical Progress: Staphylococcus aureus Infections. N. Engl. J. Med. 339, 520–32.
Martinez-Aguilar, G., Hammerman, W.A., Mason, E.O., Jr., and Kaplan, S.L. (2003). Clindamycin treatment of invasive infections caused by community-acquired, methicillin-resistant and methicillin-susceptible Staphylococcus aureus in children. Pediatr. Infect. Dis. J. 22, 593–8.
Martinez-Aguilar, G., Avalos-Mishaan. A., Hulten, K., Hammerman, W., Mason, E.O. Jr., and Kaplan, S.L. (2004). Community-acquired, methicillin-resistant and methicillin-susceptible Staphylococcus aureus musculoskeletal infections in children. Pediatr. Infect. Dis. J. 23, 701–6.
Martin, M.A. (1994). Methicillin-resistant Staphylococcus aureus: the persistent resistant nosocomial pathogen. Curr Clin Top Infect Dis. 14, 170–91.
McCracken, G.H., Jr. (1995). Emergence of resistant Streptococcus pneumoniae: a problem in pediatrics. Pediatr. Infect. Dis. J. 14, 424–8.
McIntosh, K. (2002). Community-acquired pneumonia in children. N. Engl. J. Med. 346, 429–37.
Michelow, I.C., Olsen, K., Lozano, J., Rollins, N.K., Duffy, L.B., Ziegler, T., Kauppila, J., Leinonen, M., and McCracken, G.H., Jr. (2004). Epidemiology and clinical characteristics of communityacquired pneumonia in hospitalized children. Pediatrics 113, 701–7.
Miller, L.G., Perdreau-Remington, F., Rieg, G., Mehdi, S., Perlroth, J., Bayer. A.S., Tang, A.W., Phung, T.O., and Spellberg, B. (2005). Necrotizing fasciitis caused by community-associated methicillinresistant Staphylococcus aureus in Los Angeles. N. Engl. J. Med. 352, 1445–53.
Pallares, R., Linares, J., Vadillo, M., Cabellos, C., Manresa, F., Viladrich, P.F., Martin, R., and Gudiol, F. (1995). Resistance to penicillin and cephalosporin and mortality from severe pneumococcal pneumonia in Barcelona, Spain. N. Engl. J. Med. 333, 474–80.
Rebhan, A.W., and Edwards, H.E. (1960). Staphylococcal pneumonia: a review of 329 cases. Can. Med. Assoc. J. 82, 513–7.
Sakoulas, G., Moise-Broder, P.A., Schentag, J., Forrest, A., Moellering, R.C., Jr., and Eliopoulos, G.M. (2004). Relationship of MIC and bactericidal activity to effi cacy of vancomycin for treatment of methicillin-resistant Staphylococcus aureus bacteremia. J. Clin. Microbiol 42, 2398–402.
Schrag, S.J., McGee, L., Whitney, C.G., Beall, B., Craig, A.S., Choate, M.E., Jorgensen, J.H., Facklam, R.R., and Klugman, K.P.; Active Bacterial Core Surveillance Team (2004). Emergence of Streptococcus pneumoniae with very-high-level resistance to penicillin. Antimicrob. Agents Chemother. 48, 3016–2.
Sloas, M.M., Barrett, F.F., Chesney, P.J., English, B.K., Hill, B.C., Tenover, F.C., and Leggiadro, R.J. (1992). Cephalosporin treatment failure in penicillin-and cephalosporin-resistant Streptococcus pneumoniae meningitis. Pediatr. Infect. Dis. J. 11, 662–6.
Stevens, D.L., Herr, D., Lampiris, H., Hunt. J.L., Batts, D.H., and Hafkin, B. (2002). Linezolid versus vancomycin for the treatment of methicillin-resistant Staphylococcus aureus infections. Clin. Infect. Dis. 34, 1481–90.
Tan, T.Q., Mason, E.O., Jr., Wald, E.R., Barson, W.J., Schutze, G.E., Bradley, J.S., Givner, L.B., Yogev, R., Kim, K.S., and Kaplan, S.L. (2002). Clinical characteristics of children with complicated pneumonia caused by Streptococcus pneumoniae. Pediatrics. 110, 1–6.
Tsolia, M.N., Psarras, S., Bossios, A., Audi, H., Paldanius, M., Gourgiotis, D., Kallergi. K., Kafetzis, D.A., Constantopoulos. A., and Papadopoulos, N.G. (2004). Etiology of community-acquired pneumonia in hospitalized school-age children: evidence for high prevalence of viral infections. Clin. Infect. Dis. 39, 681–6
Weigelt, J., Itani, K., Stevens, D., Lau, W., Dryden, M., and Knirsch, C. Linezolid CSSTI Study Group. (2005). Linezolid versus vancomycin in treatment of complicated skin and soft tissue infections. Antimicrob. Agents Chemother. 49, 2260–6.
Weisblum, B. (1995). Insights into erythromycin action from studies of its activity as inducer of resistance. Antimicrob. Agents Chemother. 39, 797–80.
Whitney, C.G., Farley, M.M., Hadler, J., Harrison, L.H., Bennett, N.M., Lynfield, R., Reingold. A., Cieslak, P.R., Pilishvili, T., Jackson, D., Facklam, R.R., Jorgensen, J.H., and Schuchat, A (2003). Active Bacterial Core Surveillance of the Emerging Infections Program Network. Decline in invasive pneumococcal disease after the introduction of protein-polysaccharide conjugate vaccine. N. Engl. J. Med. 348, 1737–46.
Whitney, C.G., and Klugman, K.P. (2004), Vaccines as tools against resistance: the example of pneumococcal conjugate vaccine. Semin. Pediatr. Infect. Dis. 15, 86–93.
Wunderink, R.G., Rello, J., Cammarata, S.K., Croos-Dabrera, R.V., and Kollef, M.H. (2003). Linezolid vs vancomycin: analysis of two double-blind studies of patients with methicillin-resistant Staphylococcus aureus nosocomial pneumonia. Chest 124, 1789–97.
Yu, V.L., Chiou, C.C., Feldman, C., Ortqvist, A., Rello, J., Morris, A.J., Baddour, L.M., Luna, C.M., Snydman, D.R., Ip, M., Ko, W.C., Chedid, M.B., Andremont, A., and Klugman, K.P. (2003). International Pneumococcal Study Group. An international prospective study of pneumococcal bacteremia: correlation with in vitro resistance, antibiotics administered, and clinical outcome. Clin. Infect. Dis. 37, 230–7.
Yu, V.L., and Baddour, L.M. (2004). Infection by drug-resistant Streptococcus pneumoniae is not linked to increased mortality. Clin. Infect. Dis. 39, 1086–7.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2006 Springer Science+Business Media, LLC
About this paper
Cite this paper
English, B.K., Buckingham, S.C. (2006). Impact of Antimicrobial Resistance on Therapy of Bacterial Pneumonia in Children. In: Pollard, A.J., Finn, A. (eds) Hot Topics in Infection and Immunity in Children III. Advances in Experimental Medicine and Biology, vol 582. Springer, Boston, MA . https://doi.org/10.1007/0-387-33026-7_11
Download citation
DOI: https://doi.org/10.1007/0-387-33026-7_11
Publisher Name: Springer, Boston, MA
Print ISBN: 978-0-387-31783-0
Online ISBN: 978-0-387-33026-6
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)